The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so we do use there are now serum amid biomarkers that we use and we do track these in our highest risk patients but only because we believe and I don't know if we're right by the way that lower is better and therefore if we make these changes to you and your serum ameloid levels come down that that tells us something about what's happening in your brain that's favorable
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.